Molecular epidemiological study of pyrazinamide-resistance in clinical isolates of mycobacterium tuberculosis from South India

International Journal of Molecular Sciences

Volumn 11, Issue 7, 2010, Pages 2670-2680

  Muthaiah, Muthuraj ^a   Jagadeesan, Sridharan ^a   Ayalusamy, Nisha ^a   Sreenivasan, Manupriya ^a   Prabhu, Sambamurthy Sangamesvara ^a   Muthuraj, Usharani ^b   Senthilkumar, Kamatchiyammal ^c   Veerappan, Saroja ^c  

^a Govt Hospital for Chest Diseases   (India)

^b VECTOR CONTROL RESEARCH CENTRE   (India)

^c NATIONAL ENVIRONMENTAL ENGINEERING RESEARCH INSTITUTE   (India)

Author keywords

Mycobacterium tuberculosis; pncA mutation; Pulmonary tuberculosis; PZA resistance; South India

Indexed keywords

ALANINE; BACTERIAL DNA; GLYCINE; NICOTINAMIDASE; PYRAZINAMIDE;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; DNA SEQUENCE; DRUG TREATMENT FAILURE; ENZYME ACTIVATION; GENE MUTATION; HUMAN; INDIA; LUNG TUBERCULOSIS; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR EPIDEMIOLOGY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; POLYMERASE CHAIN REACTION; PREVALENCE;

MYCOBACTERIUM TUBERCULOSIS; PNCA MUTATION; PULMONARY TUBERCULOSIS; PZA RESISTANCE; SOUTH-INDIA;

AMIDOHYDROLASES; ANTITUBERCULAR AGENTS; DRUG RESISTANCE, BACTERIAL; HUMANS; INDIA; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; PYRAZINAMIDE; TUBERCULOSIS; TUBERCULOSIS, PULMONARY;

MYCOBACTERIUM TUBERCULOSIS;

EID: 77955077527     PISSN: None     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms11072670     Document Type: Article

References (30)

1. Hou, L.; Osei Hyiaman, D.; Zhang, Z.; Wang, B.; Yang, A.; Kano, K. Molecular characterization of pncA gene mutations in Mycobacterium tuberculosis clinical isolates from China. Epidemiol Infect. 2000, 124, 227-232.
2. Barcol, P.; Cardoso, R.F.; Hiratal, R.D.C.; Leite, C.Q.F.; Pandolfi, J.R.; Sato, D.N.; Shikama, M.L.; Fiúza de Melo, F.; Mamizuka1, E.M.; Campanerut, P.A.Z.; Hirata, M.H. pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis clinical isolates from the southeast region of Brazil. J. Antimicrob. Chemother. 2006, 58, 930-935.
3. Boshoff, H.I.; Mizrahi, V. Expression of Mycobacterium smegmatis pyrazinamidase in Mycobacterium tuberculosis confers hypersensitivity to pyrazinamide and related amides.J. Bacteriol. 2000, 182, 5479-5485.
4. Boshoff, H.I.; Mizrahi, V.; Barry, C.E. Effects of pyrazinamide on fatty acid synthesis by whole mycobacterial cells and purified fatty acid synthase. J. Bacteriol. 2002, 184, 2167-2172.
5. Huang, T.; Lee, S.S.; Tu, H. Correlation between Pyrazinamide activity and pncA mutations in Mycobacterium tuberculosis isolates in Taiwan. Antimicrob. Agents Chemother. 2003, 47,3672-3673.
6. Portugal, I.; Barreiro, L.; Moniz-Pereira, J. pncA mutations in Pyrazinamide-Resistant Mycobacterium tuberculosis Isolates in Portugal. Antimicrob. Agents Chemother. 2004, 48,2736-2768.
7. Hewlett, D.; Horn, D.L.; Alfalla, C. Drug-resistant tuberculosis: Inconsistent results of pyrazinamide susceptibility testing. JAMA 1995, 12, 916-917.
8. Raynaud, C.; Lane elle, M.; Senaratne, R.H. Mechanisms of pyrazinamide resistance in mycobacteria: Importance of lack of uptake in addition to lack of pyrazinamidase activity. Microbiology 1999, 145, 1359-1367.
9. Wade, M.M.; Volokhov, D.; Peredelchuk, M. Accurate mapping of mutations of pyrazinamide-resistant Mycobacterium tuberculosis strains with a scanning-frame oligonucleotide microarray. Diagn. Microbiol. Infect. Dis. 2004, 49, 89-97.
10. Zhang, Y.; Scorpio, A.; Nikaido, H. Role of acid pH and deficient efflux of pyrazinoic acid in unique susceptibility of M. tuberculosis to pyrazinamide. J. Bacteriol. 1999, 181, 2044-2049.
11. Park, S.K.; Lee, J.Yoo.; Chang, C.L.; Lee, M.K.; Son, H.C.; Kim, C.M.; Jang, H.J.; Park, H.K.; Jeong, S.H. pncA mutations in clinical Mycobacterium tuberculosis isolates from Korea. BMC Infect. Dis. 2001, 1, 4
12. Scorpio, A.; Lindholm-Levy, P.; Heifets, L. Characterization of pnc A mutations in Pyrazinamide resistant Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 1997, 41, 540-543.
13. Sreevatsan, S.; Pan, X.; Zhang, Y.; Kreiswirth, B.N.; Musser, J.M. Mutations associated with pyrazinamide resistance in pncA of Mycobacterium tuberculosis complex organisms. Antimicrob. Agents Chemother. 1997, 41, 636-640.
14. Hirano, K.; Takahashi, M.; Kazumi, Y.; Fukasawa, Y.; Abe, C. Mutation in pncA is a major mechanism of Pyrazinamide resistance in Mycobacterium tuberculosis. Tubercle. Lung Dis. 1998, 78, 117-122.
15. Mestdagh, M.; Fonteyne, P.A.; Realini, L. Relationship between pyrazinamide resistance, loss of pyrazinamidase activity, and mutations in the pncA locus in multidrug-resistant clinical isolates of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 1999, 43, 2317-2319.
16. Hou, L.; Osei-Hyiaman, D.; Zhang, Z. Molecular characterization of pncA gene mutations in Mycobacterium tuberculosis clinical isolates from China. Epidemiol. Infect. 2000, 124, 227-32.
17. Lemaitre, N.; Sougakoff, W.; Truffot-Pernot, C. Characterization of new mutations in pyrazinamide-resistant strains of Mycobacterium tuberculosis and identification of conserved regions important for the catalytic activity of the pyrazinamidase pncA. Antimicrob. Agents Chemother. 1999, 43, 1761-1763.
18. Scorpio, A.; Lindholm-Levy, P.; Heifets, L. Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 1997, 41, 540-543.
19. Park, S.K.; Lee, J.Y.; Chang, C.L. pncA mutations in clinical Mycobacterium tuberculosis isolates from Korea. BMC Infect. Dis. 2001, 1, 4.
20. Rodrigues, V.F.S.; Telles, M.A.; Ribeiro, M.O. Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis in Brazil. Antimicrob. Agents Chemother. 2005, 49, 444-446.
21. Heifets, L.; Lindholm-Levy.P. Pyrazinamide sterilizing activity in vitro against semi-dormant Mycobacterium tuberculosis bacterial populations. Am. Rev. Respir. Dis. 1992, 145, 1223-1225.
22. Davies, A.P.; Billington, O.J.; McHugh, T.D.; Mitchison, D.A.; Gillespie, S.H. Comparison of phenotypic and genotypic methods for Pyrazinamide susceptibility testing with Mycobacterium tuberculosis. J. Clin. Microbiol. 2000, 38, 3686-3688.
23. Morlock, G.P.; Crawford, J.T.; Butler, W.R.; Brim, S.E.; Sikes, D.; Mazurek, G.H.; Woodley, C.L.; Cooksey, R.C. Phenotypic characterization of pncA mutants of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 2000, 44, 2291-2295.
24. Hirano, K.; Takahashi, M.; Kazumi, Y.; Fukasawa, Y.; Abe, C. Mutation in pncA is a major mechanism of Pyrazinamide resistance in Mycobacterium tuberculosis. Tubercle. Lung. Dis. 1998, 78, 117-122.
25. Isenberg, H.D. Mycobacteriology: Identification tests for mycobacteria. In Clinical Microbiology Procedure Handbook; Isenberg, H.D., Ed.; ASM Press: Washington, DC, USA, 1995; Volume 1, pp.12-17.
26. Mani, C.; Selvakumar, N.; Kumar, V.; Narayanan, S.; Narayanan, P.R. Comparison of DNA sequencing, PCR-SSCP and PhaB assays with indirect sensitivity testing for detection of rifampcin resistance in Mycobacterium tuberculosis. Int. J. Tuber. Lung. Dis. 2003, 7, 625-659.
27. Fletcher, H.A.; Donoghue, H.D.; Taylor, G.M.; Adri, G.M.; Van der Zanden, A.G.M.; Spigelman, M. Molecular analysis of Mycobacterium tuberculosis DNA from a family of 18th century Hungarians. Microbiology 2003, 149, 143-151.
28. Scorpio, A.; Lindholm-levy, P.; Heifets, L.; Gilman, R.; Siddiqi, S.; Cynamon, M.; Zhang, Y. Characterization of pncA Mutations in Pyrazinamide-Resistant Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 1997, 41, 540-543.
29. Hathaway, L.J.; Brugger, S.; Martynova, A.; Aebi, S.; Muhlemann, K. Use of the Agilent 2100 Bioanalyzer for Rapid and Reproducible Molecular Typing of Streptococcus pneumoniae. J. Clin. Microbiol. 2007, 45, 803-809.
30. Altschul, S.F.; Madden, T.L.; Schaffer, A.A.; Zhang, J.; Zhang, Z.; Miller, W.; Lipman, D.J. Gapped BLAST and PSI-BLAST: A new generation of protein database search programs.J. Nucleic. Acids Res. 1997, 25, 3389-3402.